Potential cost savings due the route of administration of oncology drugs: A micro-costing study of intravenous and subcutaneous administration of trastuzumab and rituximab in The Netherlands

2018

Anti-Cancer Drugs , Volume 29 p. 791- 801

Additional Metadata
Persistent URL	hdl.handle.net/1765/110823
Journal	Anti-Cancer Drugs
Organisation	Department of Otorhinolaryngology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Franken, M.-C., Kanters, T., Coenen, J.L., De Jong, P., Koene, H., Lugtenburg, P., … Uyl-de Groot, C. (2018). Potential cost savings due the route of administration of oncology drugs: A micro-costing study of intravenous and subcutaneous administration of trastuzumab and rituximab in The Netherlands. Anti-Cancer Drugs, 29, 791–801. Retrieved from http://hdl.handle.net/1765/110823

Publication